Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Treatment for EBV-triggered HLH usually combines HLH-directed therapy (dexamethasone, etoposide, cyclosporine, or ruxolitinib) with measures to control the EBV infection and any…
In cardiac surgery patients with coagulopathy, prothrombin complex concentrate (PCC) reduces chest tube drainage and red blood cell transfusions compared with fresh frozen…
For bleeding after heart surgery, prothrombin complex concentrate (PCC) may reduce chest tube drainage and the need for reoperation compared with fresh-frozen plasma (FFP), but…
Delayed treatment in children with sickle cell disease and osteomyelitis increases risks of bone damage, infection spread, and severe complications like sepsis.
Yes, CAR-T cell therapy is highly effective for hematologic malignancies, with success in blood cancers like ALL, but faces challenges in solid tumors.
For high-risk GIST patients, 5-year relapse-free survival is about 74% with ≤3 years of adjuvant imatinib and 84% with >3 years, based on a 2026 retrospective study.
Treatment with eltrombopag and immunosuppression leads to an increase in clonal mutations over time, with two main patterns of evolution: early changes involving chromosome 7 and…
Yes, longitudinal TCR profiling can predict GVHD in stem cell transplant patients, with studies showing AUC values around 0.83 for GVHD prediction.
Frontline ATRA-ATO therapy is highly effective for newly diagnosed APL, with complete remission rates over 94% and 3-year survival above 93% in clinical trials.
Yes, Rytelo (imetelstat) is FDA-approved for adults with low- to intermediate-1 risk MDS and transfusion-dependent anemia who need ≥4 RBC units over 8 weeks and have not…
Yes, Revlimid (lenalidomide) is FDA-approved for transfusion-dependent anemia in low- or intermediate-1-risk MDS with a deletion 5q abnormality.
Yes, the FDA approved Rytelo (imetelstat) in June 2024 for adults with low- to intermediate-1 risk MDS who have transfusion-dependent anemia and have not responded to or are…
Patients with VEXAS syndrome often respond quickly to corticosteroids but struggle with long-term dependence. Hypomethylating agents like azacitidine show gradual, sustained…
A Chinese study of 16 patients found that p.M41V is the dominant UBA1 mutation, and most showed typical symptoms like anemia, skin lesions, and ear inflammation, similar to…
All available studies on VEXAS syndrome included only male patients, so researchers could not compare treatment responses between men and women.
About 1.2% of leukemia patients experience retinal vein occlusion, according to a meta-analysis of 1,016 participants.
Research shows that high birth weight, maternal diabetes, hypertension, history of abortion, and cesarean sections are linked to a higher risk of childhood acute leukemia.
A specific case report shows that combining azacytidine with ruxolitinib helped a patient with connective tissue disease, CMML, and myelofibrosis by reducing fever, correcting…
A lower neutrophil-to-lymphocyte ratio (NLR) before starting immune therapy predicts longer survival and better response rates in metastatic cervical cancer, while a higher ratio…
CMML can be misdiagnosed as ITP when thrombocytopenia is the first symptom; immunosuppressive therapy may temporarily raise platelets, but the underlying CMML progresses…
Hematopoietic stem cell (HSC) therapies can reset the immune system to stop autoimmune attacks, though they carry risks like infection and require careful nutrition and monitoring.
Yes, Lynch syndrome increases the risk of bladder and kidney cancers, especially in people with MSH2 mutations.
Gene therapy reduces annualized bleeding rates in adults with severe Hemophilia A by a standardized mean difference of -0.72 compared to standard factor treatment, though…
Non-clotting factor therapies like emicizumab and concizumab are effective for preventing bleeding in both Hemophilia A and Hemophilia B.
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.